AtriCure
ATRC
213 hedge funds and large institutions have $1.42B invested in AtriCure in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 70 increasing their positions, 72 reducing their positions, and 23 closing their positions.
806% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $138K
70% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 23
6% more funds holding
Funds holding: 201 → 213 (+12)
3% more capital invested
Capital invested by funds: $1.39B → $1.42B (+$36.7M)
3% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 72
5.99% less ownership
Funds ownership: 101.38% → 95.39% (-6%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$13.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.65M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.55M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.39M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$34.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$28.6M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$9.67M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$8.43M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$7.5M |
ATRC Hedge Fund Activity: Q4 2024 in Review
213 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2024, worth a combined $1.42B — up 2.6% from $1.39B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ATRC positions and 23 closed out — a net gain of 16 holders — while 70 added to existing stakes and 72 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $13.9M. The largest seller was Divisadero Street Capital Management, cutting an estimated $34.8M.
- 213 institutional investors held AtriCure (ATRC) as of Q4 2024, up from 201 in Q3 2024.
- Funds reported $1.42B of AtriCure stock for Q4 2024, up 2.6% quarter-over-quarter.
- 39 funds opened new AtriCure positions in Q4 2024 and 23 closed out, a net change of +16 holders.
- The largest AtriCure buyer in Q4 2024 was Goldman Sachs, an estimated $13.9M added.
- The largest AtriCure seller in Q4 2024 was Divisadero Street Capital Management, an estimated $34.8M sold.
Based on aggregated 13F filings for Q4 2024.